Literature DB >> 15722559

RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-alpha secretion.

Carol A Rouzer1, Aaron T Jacobs, Chetan S Nirodi, Philip J Kingsley, Jason D Morrow, Lawrence J Marnett.   

Abstract

Studies of the response of RAW264.7 cells (RAW) to lipopolysaccharide (LPS) were carried out to determine why these cells do not demonstrate the prostaglandin (PG)-dependent autocrine regulation of tumor necrosis factor-alpha (TNF-alpha) secretion observed in primary resident peritoneal macrophages (RPMs). The major cyclooxygenase (COX) product of LPS-stimulated RAW was PGD2, with lesser amounts of PGE2. LPS-treated RAW produced PGs more slowly and reached their maximal PG synthetic rate later than did LPS-treated RPMs, as a result of lower constitutive COX-1 expression and a slower rate of COX-2 induction. Cytosolic phospholipase A2 and levels of free arachidonic acid were similar in RAW and RPMs. In contrast to RPMs, LPS-treated RAW produced high quantities of TNF-alpha, which were not altered in the presence of COX inhibitors. This failure of endogenous PGs to suppress TNF-alpha secretion was explained by the absence of the prostaglandin D2 receptor and the low levels of PGE2 produced during the first 2 h of the LPS response. These studies demonstrate that autocrine regulation of TNF-alpha secretion in response to LPS is greatly facilitated by a COX-1-mediated rapid accumulation of PGs as well by a correspondence between the PGs produced and the receptors expressed by the cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722559     DOI: 10.1194/jlr.M500006-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  An adenoviral vector for probing promoter activity in primary immune cells.

Authors:  Pulak Tripathi; Rajat Madan; Claire Chougnet; Senad Divanovic; Xiaojing Ma; Larry M Wahl; Thomas Gajewski; Christopher L Karp; David A Hildeman
Journal:  J Immunol Methods       Date:  2006-02-20       Impact factor: 2.303

2.  Protein Modification by Endogenously Generated Lipid Electrophiles: Mitochondria as the Source and Target.

Authors:  William N Beavers; Kristie L Rose; James J Galligan; Michelle M Mitchener; Carol A Rouzer; Keri A Tallman; Connor R Lamberson; Xiaojing Wang; Salisha Hill; Pavlina T Ivanova; H Alex Brown; Bing Zhang; Ned A Porter; Lawrence J Marnett
Journal:  ACS Chem Biol       Date:  2017-06-28       Impact factor: 5.100

3.  Nitric oxide, oxygen, and superoxide formation and consumption in macrophages and colonic epithelial cells.

Authors:  Melanie P Chin; David B Schauer; William M Deen
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

4.  An Activity-Based Sensing Approach for the Detection of Cyclooxygenase-2 in Live Cells.

Authors:  Anuj K Yadav; Christopher J Reinhardt; Andres S Arango; Hannah C Huff; Liang Dong; Michael G Malkowski; Aditi Das; Emad Tajkhorshid; Jefferson Chan
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-06       Impact factor: 15.336

5.  Biosynthesis of hemiketal eicosanoids by cross-over of the 5-lipoxygenase and cyclooxygenase-2 pathways.

Authors:  Markus Griesser; Takashi Suzuki; Noemi Tejera; Stacey Mont; William E Boeglin; Ambra Pozzi; Claus Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

6.  Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.

Authors:  Carol A Rouzer; Pavlina T Ivanova; Mark O Byrne; Stephen B Milne; Lawrence J Marnett; H Alex Brown
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

Review 7.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

8.  Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.

Authors:  Kyle L Poulsen; Ryan P Albee; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2014-02-13       Impact factor: 4.030

9.  A macrophage cell model for selective metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Matthew W Buczynski; Edward A Dennis; Seth M Cohen
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

10.  Analysis of inflammatory and lipid metabolic networks across RAW264.7 and thioglycolate-elicited macrophages.

Authors:  Mano R Maurya; Shakti Gupta; Xiang Li; Eoin Fahy; Ashok R Dinasarapu; Manish Sud; H Alex Brown; Christopher K Glass; Robert C Murphy; David W Russell; Edward A Dennis; Shankar Subramaniam
Journal:  J Lipid Res       Date:  2013-06-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.